Ultrafiltration device and method for secondary two-stage tangential flow separation, purification and concentration of exosomes

The ultrafiltration device for separating, purifying and concentrating exosomes through a secondary two-stage tangential flow is used to drive the liquid flow using a tangential flow ultrafiltration system and a peristaltic pump circulation pump, solving the complex operation of exosomes during separation, purification and concentration. High-quality and cost problems have achieved efficient and low-cost exosome separation and concentration effects.

CN114471163BActive Publication Date: 2024-12-06NINGBO YONGHENG YAOYAO INTELLIGENT TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111520737.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-13
Publication Date
2024-12-06
Estimated Expiration
2041-12-13

AI Technical Summary

Technical Problem

In the prior art, the separation, purification and concentration process of exosomes is complex, requires frequent maintenance and is costly, making it difficult to meet market demand.

Method used

The ultrafiltration device for separating, purifying and concentrating exosomes using a secondary two-stage tangential flow, including a first and a second stage tangential flow ultrafiltration system, a first filter membrane and a second filter membrane connected through a pipeline, The peristaltic pump and circulating pump are used to drive the liquid flow to achieve efficient exosome separation and concentration.

Benefits of technology

It realizes rapid and large-scale separation, purification and concentration of exosomes, reduces operational complexity and maintenance costs, improves purity and collection efficiency, and is suitable for commercial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114471163B_ABST
    Figure CN114471163B_ABST
Patent Text Reader

Abstract

The present invention provides an ultrafiltration device for secondary two-stage tangential flow separation, purification and concentration of exosomes, including a first-stage tangential flow ultrafiltration system, a second-stage tangential flow ultrafiltration system, a peristaltic pump and a circulation pump connected by pipelines, wherein the peristaltic pump and the circulation pump are used to drive the flow of liquid inside the ultrafiltration device; and the first-stage tangential flow ultrafiltration system and the second-stage tangential flow ultrafiltration system are respectively provided with a first filter membrane and a second filter membrane, and the pore size of the filter pores of the second filter membrane is smaller than the pore size of the filter pores of the first filter membrane. The present invention also provides an ultrafiltration method for secondary two-stage tangential flow separation, purification and concentration of exosomes, including cyclic ultrafiltration of a liquid to be extracted, and finally obtaining high-purity exosomes. The present invention has high promotion value and commercial value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to an ultrafiltration device and method for separating, purifying and concentrating exosomes using a secondary two-stage tangential flow. Background Art

[0002] At present, the separation, enrichment and extraction methods of exosomes mainly rely on manual operations. The main technical methods include centrifugation, precipitation, ultrafiltration, immunoaffinity and microfluidics. With the development of science and technology and the popularization of people's health concepts and pursuit of beauty, the market demand for exosomes has increased. The large-scale extraction, separation and purification of traditional exosome separation technologies are limited by insufficient production capacity, resulting in a supply shortage of exosomes. Therefore, large-scale production of exosomes is imminent.

[0003] Ultracentrifugation has long been considered the gold standard for isolating and extracting exosomes. This method uses multiple differential centrifugations to separate exosomes based on sedimentation coefficient, size, and shape. First, the supernatant of the mesenchymal stem cell (MSC) culture medium was collected and centrifuged at 300g-500g for 10 minutes at 4°C to obtain supernatant 1 and precipitate 1. This step is to remove living cells; next, supernatant 1 was centrifuged at 2000g at 4°C for 10-20 minutes to remove dead cells, obtaining supernatant 2 and precipitate 2; supernatant 2 was centrifuged at 4°C, 10,000g, for 20-30 minutes to obtain supernatant 3 and precipitate 3. This step is to remove cell debris; next, supernatant 3 was centrifuged at 4°C, 100,000g, for 70-120 minutes to obtain supernatant 4 and precipitate 4. This step is to remove vesicle structures; supernatant 4 was then centrifuged at 4°C, 100,000g, for 70-120 minutes to obtain supernatant 5 and precipitate 5. Precipitate 5 is the exosome. The exosomes are then resuspended in PBS to obtain an exosome suspension. This technique takes approximately 5 to 6 hours.

[0004] Exosome isolation and extraction are currently mostly manual, cumbersome, and time-consuming processes. Existing automated extraction equipment offers low yields, is time-consuming, and expensive, making it difficult to meet market demand. Exosome manufacturers urgently need a platform that can rapidly and efficiently obtain high-purity exosomes in large quantities. For example, ultracentrifugation is cumbersome, time-consuming, and labor-intensive, relying heavily on operator experience. Collection results are often reproducible, and recovery rates are low, limiting its application in industrial production and clinical applications. Chromatographic methods such as affinity chromatography and ion exchange chromatography offer some advantages in industrial purification. While they can quantify and determine the concentration of the target purified product, they are limited in their industrialization due to the column's requirements for feed sample pH, buffering, and conductivity, as well as the isoelectric point of the purified product itself. Immunomagnetic bead-based and microfluidic methods are costly, uneconomical, and require high technical skills. While suitable for micro-scale purification, they are difficult to manufacture on a large scale.

[0005] Furthermore, with advances in biotechnology, technologies that can isolate and purify target products from crude biological product solutions, such as cell culture supernatants, have gradually begun to be used for the commercial production of biopharmaceuticals. For example, affinity chromatography methods are based on affinity. Affinity-based chromatography separates biomolecules based on partially specific interactions between the target product and a solid matrix. Consequently, the target product binds specifically to the solid matrix, while other nonspecific components that cannot bind flow out of the system. The target product can then be harvested by eluting the chromatography column. Although affinity chromatography can produce highly specific and very pure products, the filler used in affinity chromatography is over 10 times heavier than other materials. Furthermore, maintenance, replacement, process development, and testing represent significant costs.

[0006] In addition, traditional dead-end filtration technology places the feed liquid upstream of the membrane, and then, driven by the pressure difference, water and particles smaller than the membrane pores pass through the membrane. Particles larger than the membrane pores are retained by the membrane. The disadvantage of dead-end filtration is that as time goes by, the number of particles accumulated on the membrane surface also increases, the filtration resistance increases, and the membrane permeation rate decreases. Therefore, dead-end filtration is intermittent and must be stopped periodically to clean the contamination layer on the membrane surface or replace the membrane. It is also only suitable for filtration of liquids with relatively small flux and low solid content. Tangential flow filtration is suitable for larger-scale feed liquid filtration. The liquid flow generates shear force on the filter end surface, reducing the accumulation of filter cake or gel layer and ensuring a stable filtration speed. Summary of the Invention

[0007] The technical problem to be solved by the present invention is to provide a secondary two-stage tangential flow ultrafiltration device for separation, purification and concentration of exosomes, so as to solve the problems of complex operation, frequent maintenance and high cost in the current traditional methods of separation, purification and concentration of exosomes.

[0008] To address the above-mentioned problems, the present invention provides a two-stage tangential flow ultrafiltration device for separating, purifying, and concentrating exosomes, characterized in that it comprises a first-stage tangential flow ultrafiltration system, a first peristaltic pump, and a second-stage tangential flow ultrafiltration system sequentially connected by pipelines, wherein the first peristaltic pump is used to drive the liquid inside the first-stage tangential flow ultrafiltration system to flow to the second-stage tangential flow ultrafiltration system; and the first peristaltic pump does not perform a filtering function, and the exosomes can pass through the first peristaltic pump;

[0009] A first filter membrane is provided in the first-stage tangential flow ultrafiltration system, and a second filter membrane is provided in the second-stage tangential flow ultrafiltration system. The first filter membrane and the second filter membrane are connected through the pipeline; the filtration pore diameter of the second filter membrane is smaller than the filtration pore diameter of the first filter membrane.

[0010] As a preferred solution, the filtration pore diameter of the first filter membrane is greater than or equal to 0.18 μm, and the filtration pore diameter of the second filter membrane is less than or equal to 0.03 μm.

[0011] As a preferred solution, the first filter membrane and the second filter membrane are both cassette-type flat membranes.

[0012] As a preferred solution, a filtrate container is provided in the first-stage tangential flow ultrafiltration system, and an enriched liquid container is provided in the second-stage tangential flow ultrafiltration system, and the filtrate container is connected to the first filter membrane through the pipeline, and the enriched liquid container is connected to the upstream and downstream of the second filter membrane through the pipeline, so that when the liquid flows in the ultrafiltration device, the liquid passing through the first filter membrane flows into the filtrate container, and the liquid that does not pass through the second filter membrane flows into the enriched liquid container.

[0013] As a preferred solution, a one-way valve and a circulation pump are provided between the enriched liquid container and the second filter membrane. The one-way valve directs flow from the enriched liquid container to the second filter membrane, and the circulation pump is used to drive the circulation of liquid within the second-stage tangential flow ultrafiltration system. The first peristaltic pump can drive the liquid in the pipeline to flow, introducing the extracted liquid from the pipeline into the first-stage tangential flow ultrafiltration system and the second-stage tangential flow ultrafiltration system for ultrafiltration.

[0014] The circulation pump is arranged in the second-stage tangential flow ultrafiltration system, which can drive the liquid to be ultrafiltered multiple times in the second-stage tangential flow ultrafiltration system to improve the extraction rate of exosomes and improve the effect of concentrating and purifying exosomes.

[0015] As a preferred solution, a one-way valve is installed between the enriched liquid container and the second filter membrane, with the one-way valve directing flow from the enriched liquid container to the second filter membrane. This prevents liquid in the pipeline from flowing back through the second filter membrane into the enriched liquid container during operation of the circulation pump and the first peristaltic pump, thus preventing the purity of the enriched liquid from being affected by this backflow.

[0016] As a preferred solution, the outlet end of the second filter membrane is connected to a recovery container, and the recovery container is used to recover the liquid that passes through the second filter membrane after the circulation of the circulation pump is completed.

[0017] As a preferred solution, the pipeline at the inlet end of the first filter membrane is connected to a container for liquid to be extracted, so that when the liquid flows through the ultrafiltration device, the liquid that has not passed through the first filter membrane flows into the container for liquid to be extracted.

[0018] As a preferred solution, a second peristaltic pump is provided in the first-stage tangential flow ultrafiltration system, and the inlet of the second peristaltic pump is connected to the container of liquid to be extracted, and the outlet of the second peristaltic pump is connected to the inlet end of the first filter membrane; the second peristaltic pump is used to drive the liquid in the container of liquid to be extracted to flow to the first-stage tangential flow ultrafiltration system.

[0019] The tangential flow filtration (TFF) technology employed in the present invention enables efficient and rapid separation and purification of biomolecules. It is capable of concentrating and desalting sample solutions ranging from tens of milliliters to thousands of liters. It can also be used to separate biomolecules of varying sizes, collect cell suspensions, and remove and clarify cells and cell debris from fermentation broths and cell lysates. Tangential flow filtration refers to a filtration method in which the direction of liquid flow is perpendicular to the direction of filtration. The liquid flow generates shear forces on the surface of the filter medium, reducing the accumulation of cake and gel layers, thereby ensuring a stable filtration rate. Furthermore, the tangential flow ultrafiltration system of the present invention is capable of large-scale, rapid separation, purification, and concentration of stem cell culture supernatant containing exosomes, and can be performed in a pollution-free manner. The present invention can effectively separate, concentrate and purify exosomes from a liquid to be extracted containing exosomes, and has simple operation and low cost. The concentrated exosomes are also easy to collect, and the exosomes can be continuously concentrated. The device of the present invention can directly separate, purify and concentrate the supernatant of cell culture medium containing exosomes in a non-destructive, pollution-free, homogeneous and high-throughput manner, and has high commercial value and promotion value.

[0020] Another technical problem to be solved by the present invention is to provide a secondary two-stage tangential flow ultrafiltration method for separation, purification and concentration of exosomes to solve the problems of cumbersome operation and high cost of current conventional methods.

[0021] The present invention adopts the following scheme: a secondary two-stage tangential flow ultrafiltration method for separating, purifying and concentrating exosomes, using the above-mentioned ultrafiltration device for ultrafiltration.

[0022] As a priority solution, the following steps are included:

[0023] S1: introducing the liquid to be extracted containing exosomes into a pipeline, and the liquid to be extracted flows through the first filter membrane of the first-stage tangential flow ultrafiltration system for primary filtration to obtain a filtrate, removing impurities such as dead cells, cell debris, and large vesicles; the pore size of the filtration pores of the first filter membrane is larger than that of the exosomes;

[0024] S2: The filtrate of step S1 flows through the second filter membrane of the second-stage tangential flow ultrafiltration system for re-filtration for enrichment and concentration to obtain an enriched liquid filtered by the second filter membrane and purified exosomes; the pore size of the second filter membrane is smaller than that of the exosomes.

[0025] Exosomes can pass through the ultrafiltration membrane of the first-stage tangential flow ultrafiltration system. After passing through the membrane of the first-stage tangential flow ultrafiltration system, the exosomes are located in the filtrate of the first-stage tangential flow ultrafiltration system. Exosomes cannot pass through the ultrafiltration membrane of the second-stage tangential flow ultrafiltration system.

[0026] S3: The exosome-enriched liquid is driven by a circulation pump to undergo recirculation ultrafiltration, and finally the purified and concentrated exosome-enriched liquid is obtained in the second ultrafiltration system.

[0027] As a preferred solution, in step S1, the exosome-containing liquid to be extracted is the supernatant of the cell culture medium.

[0028] As a preferred embodiment, in step S3, the circulation pump is driven within the second tangential flow ultrafiltration system. Specifically, after treatment in step S2, the enriched liquid is passed into the second tangential flow ultrafiltration system for re-ultrafiltration, with the re-ultrafiltration being performed once or more. The exosomes are located in a sample pool within the second-stage tangential flow ultrafiltration system. The liquid in the sample pool can circulate a certain number of times, and this circulation operation is controlled by the circulation pump within the second-stage tangential flow ultrafiltration system.

[0029] The secondary two-stage tangential flow ultrafiltration method for separation, purification, and concentration of exosomes of the present invention can effectively ultrafilter the liquid to be extracted containing exosomes, separate the exosomes in the liquid to be extracted into the second tangential flow ultrafiltration system, and the circulation system provided by the present invention can repeatedly ultrafilter the liquid inside the device multiple times. The method of the present invention can directly separate, purify, and concentrate the liquid to be extracted containing exosomes in a non-destructive, pollution-free, homogeneous, and high-throughput manner; the exosomes finally prepared have a high content, and the ultrafiltration method is simple and easy to operate, without the need for cumbersome equipment and multiple manual operations, and is suitable for commercial promotion and has high economic value. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 1 It is a structural schematic diagram of the present invention;

[0031] Figure 2 The figure is a flow diagram of liquid in the pipeline of the present invention; wherein the arrows represent the flow direction of the liquid in the pipeline;

[0032] Description of reference numerals:

[0033] 1. First-stage tangential flow ultrafiltration system; 11. First filter membrane; 12. Filtrate container; 2. Second-stage tangential flow ultrafiltration system; 21. Second filter membrane; 22. Enriched liquid container; 3. Pipeline; 4. First peristaltic pump; 5. Circulation pump; 6. One-way valve; 7. Container for the liquid to be extracted; 8. Recovery container; 9. Second peristaltic pump. DETAILED DESCRIPTION

[0034] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, specific embodiments of the present invention are described in detail below with reference to the accompanying drawings.

[0035] Example 1:

[0036] like Figure 1 、 Figure 2 As shown, this embodiment provides a secondary two-stage tangential flow ultrafiltration device for separation, purification and concentration of exosomes, comprising a first-stage tangential flow ultrafiltration system 1, a first peristaltic pump 4 and a second-stage tangential flow ultrafiltration system 2 connected in sequence by a pipeline 3, and a circulation pump 5 is provided in the second-stage tangential flow ultrafiltration system 2; the first peristaltic pump 4 and the circulation pump 5 are used to drive the flow of liquid inside the ultrafiltration device. Specifically, the first peristaltic pump 4 is used to drive the liquid, introduce the liquid from the container containing the extract into the pipeline 3, and then continue to drive it to flow through the first-stage tangential flow ultrafiltration system 1 and the second-stage tangential flow ultrafiltration system 2;

[0037] The first-stage tangential flow ultrafiltration system 1 is provided with a first filter membrane and a filtrate container 12, and the second-stage tangential flow ultrafiltration system 2 is provided with a second filter membrane and an enriched liquid container 22. Both the first and second filter membranes are cassette-type flat membranes. The first filter membrane 11 and the filtrate container 12 are located downstream of the first filter membrane 11, and the enriched liquid container 22 is located downstream of the second filter membrane. The pore size of the second filter membrane is smaller than that of the first filter membrane, allowing exosomes to pass through the ultrafiltration membrane of the first-stage tangential flow ultrafiltration system 1. After passing through the membrane of the first-stage tangential flow ultrafiltration system 1, the exosomes are located in the filtrate of the first-stage tangential flow ultrafiltration system 1. The exosomes cannot pass through the ultrafiltration membrane of the second-stage tangential flow ultrafiltration system 2 and are located in the enriched liquid container 22 of the second-stage tangential flow ultrafiltration system 2. After multiple cycles, the exosomes are collected together to obtain concentrated and purified exosomes.

[0038] The filter membrane in the tangential flow ultrafiltration system of the present invention does not have any brand requirements. The filter membrane requirements that can meet the present invention are that the pore size range meets the above-mentioned requirements (the pore size range of the filter membrane of the first-stage tangential flow ultrafiltration system 1 is greater than or equal to 0.18 μm, and the pore size range of the filter membrane of the second-stage tangential flow ultrafiltration system 2 is less than or equal to 0.03 μm), the pH range that can be tolerated is pH 7.6 ± 0.6, low protein adsorption, and high chemical tolerance. The liquid to be extracted is passed through the first-stage tangential flow ultrafiltration system 1 with a pore size greater than or equal to 0.18 μm to remove impurities and reduce pollutants. The first peristaltic pump 4 passes the collected filtrate of the first-stage tangential flow ultrafiltration system 1 into the second-stage tangential flow ultrafiltration system 2 with a pore size less than or equal to 0.03 μm for concentration and enrichment.

[0039] The pipeline 3 at the inlet end of the first filter membrane 11 is connected to a container 7 for liquid to be extracted through a second peristaltic pump 9. The second peristaltic pump is used to drive the liquid from the container 7 for liquid to be extracted to leave the pipeline and enter the first filter membrane 11; the outlet end of the second filter membrane 21 is connected to a recovery container 8.

[0040] The outlet of the second filter membrane 21 is connected to two pipelines, one connected to the enriched liquid container 22 and the other connected to the recovery container 8. The outlet of the first filter membrane 11 is also connected to two pipelines, one connected to the filtrate container 12 and the other connected to the unextracted liquid container 7. During operation of the device, the first filter membrane 11 filters out large particles and other substances, which flow directly into the filtrate container 12 through the pipelines. The filtered solution containing exosomes is further driven by the first peristaltic pump 4 and flows into the second filter membrane 21. Because the diameter of the exosomes is larger than the pore size of the filter pores of the second filter membrane 21, the exosomes are trapped on the upper part of the second filter membrane 21. The filtered liquid flows into the recovery container 8, and the trapped exosomes are ultimately discharged into the enriched liquid container 22.

[0041] The first peristaltic pump 4 is disposed between the first-stage tangential flow ultrafiltration system 1 and the second-stage tangential flow ultrafiltration system 2, specifically, between the filtrate container 12 and the second filter membrane 21. The first peristaltic pump 4 does not perform a filtering function, and exosomes can pass through the first peristaltic pump 4.

[0042] A one-way valve 6 is provided between the enriched liquid container 22 and the second filter membrane, and the flow direction of the one-way valve 6 is from the enriched liquid container 22 to the second filter membrane. This prevents the liquid in the pipeline 3 from flowing back through the second filter membrane to the enriched liquid container 22 during the operation of the circulation pump 5 and the first peristaltic pump 4, thereby preventing the purity of the enriched liquid from being affected by the backflow.

[0043] The circulation pump 5 is disposed within the second-stage tangential flow ultrafiltration system 2 and is used to drive the circulation of the liquid within the second-stage tangential flow ultrafiltration system 2. The circulation pump 5 is specifically disposed upstream of the second filter membrane 21 and the one-way valve 6, and a one-way valve 6 is disposed between the circulation pump 5 and the second filter membrane 21. This drives the liquid to circulate multiple times between the enriched liquid container 22 and the second filter membrane 21, thereby driving the liquid to undergo multiple ultrafiltrations within the second-stage tangential flow ultrafiltration system 2, ultimately increasing the ultrafiltration exosome extraction rate and improving the effect of concentrating and purifying the exosomes. The liquid in the second-stage tangential flow ultrafiltration system 2 can circulate a certain number of times, and this operation is controlled by the circulation pump 5 on the second-stage tangential flow ultrafiltration system 2.

[0044] Example 2:

[0045] This embodiment provides a secondary two-stage tangential flow ultrafiltration method for separation, purification and concentration of exosomes. Figure 2 As shown in the flowchart, it mainly includes the following steps:

[0046] S1: The liquid to be extracted containing exosomes is driven by the second peristaltic pump 9 into the pipeline 3. The liquid to be extracted flows through the first filter membrane of the first-stage tangential flow ultrafiltration system 1 for primary filtration to obtain a filtrate, and impurities such as dead cells, cell debris, and large vesicles are removed. The pore size of the filtration pores of the first filter membrane is larger than that of the exosomes. The filtrate flows into the filtrate container 12. The liquid to be extracted containing exosomes is the supernatant of the cell culture medium.

[0047] S2: The filtrate from step S1 is driven by the first peristaltic pump 4 and continues to be passed from the filtrate container 12 to the downstream second-stage tangential flow ultrafiltration system 2, and flows through the second filter membrane of the second-stage tangential flow ultrafiltration system 2 for re-filtration for enrichment and concentration, thereby obtaining an enriched liquid filtered by the second filter membrane and purified exosomes, and the enriched liquid flows into the enriched liquid container 22; the pore size of the second filter membrane is smaller than that of the exosomes.

[0048] The pore size of the first filter membrane is 0.18 μm, and the pore size of the second filter membrane is 0.03 μm;

[0049] Exosomes can pass through the ultrafiltration membrane of the first-stage tangential flow ultrafiltration system 1. After passing through the membrane of the first-stage tangential flow ultrafiltration system 1, the exosomes are located in the filtrate of the first-stage tangential flow ultrafiltration system 1. Exosomes cannot pass through the ultrafiltration membrane of the second-stage tangential flow ultrafiltration system 2.

[0050] S3: The enriched liquid in the enriched liquid container 22 is circulated and ultrafiltered again by the circulation pump 5, and finally the purified and concentrated exosome enriched liquid is obtained in the enriched liquid container 22 of the second ultrafiltration system.

[0051] Example 3:

[0052] This embodiment provides a secondary two-stage tangential flow ultrafiltration method for separation, purification and concentration of exosomes. Figure 2 As shown in the flowchart, it mainly includes the following steps:

[0053] S1: The liquid to be extracted containing exosomes is driven by the second peristaltic pump 9 into the pipeline 3. The liquid to be extracted flows through the first filter membrane of the first-stage tangential flow ultrafiltration system 1 for primary filtration to obtain a filtrate, and impurities such as dead cells, cell debris, and large vesicles are removed. The pore size of the filtration pores of the first filter membrane is larger than that of the exosomes. The filtrate flows into the filtrate container 12. The liquid to be extracted containing exosomes is the supernatant of the cell culture medium.

[0054] S2: The filtrate in step S1 is driven by the first peristaltic pump 4 and continues to flow from the filtrate container 12 to the downstream pipeline 3, flows through the second filter membrane of the second-stage tangential flow ultrafiltration system 2, and is filtered again for enrichment and concentration to obtain the enriched liquid filtered by the second filter membrane and the purified exosomes, and the enriched liquid flows into the enriched liquid container 22; the pore size of the second filter membrane is smaller than that of the exosomes.

[0055] The pore size of the first filter membrane is 0.20 μm, and the pore size of the second filter membrane is 0.01 μm;

[0056] Exosomes can pass through the first filter membrane 11 of the first-stage tangential flow ultrafiltration system 1. After passing through the first filter membrane 11 of the first-stage tangential flow ultrafiltration system 1, the exosomes are located in the filtrate container 12 of the first-stage tangential flow ultrafiltration system 1. Exosomes cannot pass through the second filter membrane 21 of the second-stage tangential flow ultrafiltration system 2. After flowing through the second filter membrane 21, the exosomes remain on the second filter membrane 21.

[0057] S3: The enriched liquid in the enriched liquid container 22 is circulated and ultrafiltered again by the circulation pump 5, and finally the purified and concentrated exosome enriched liquid is obtained in the enriched liquid container 22 of the second ultrafiltration system.

[0058] Example 3:

[0059] This embodiment provides a secondary two-stage tangential flow ultrafiltration method for separation, purification and concentration of exosomes. Figure 2 As shown in the flowchart, it mainly includes the following steps:

[0060] S1: The liquid to be extracted containing exosomes is driven by the second peristaltic pump 9 into the pipeline 3. The liquid to be extracted flows through the first filter membrane of the first-stage tangential flow ultrafiltration system 1 for primary filtration to obtain a filtrate, and impurities such as dead cells, cell debris, and large vesicles are removed. The pore size of the filtration pores of the first filter membrane is larger than that of the exosomes. The filtrate flows into the filtrate container 12. The liquid to be extracted containing exosomes is the supernatant of the cell culture medium.

[0061] S2: The filtrate in step S1 is driven by the first peristaltic pump 4 and continues to flow from the filtrate container 12 to the downstream second-stage tangential flow ultrafiltration system 2, and flows through the second filter membrane of the second-stage tangential flow ultrafiltration system 2 for re-filtration for enrichment and concentration, thereby obtaining an enriched liquid filtered by the second filter membrane and purified exosomes, and the enriched liquid flows into the enriched liquid container 22; the pore size of the second filter membrane is smaller than that of the exosomes.

[0062] The pore size of the first filter membrane is 0.19 μm, and the pore size of the second filter membrane is 0.02 μm;

[0063] Exosomes can pass through the ultrafiltration membrane of the first-stage tangential flow ultrafiltration system 1. After passing through the membrane of the first-stage tangential flow ultrafiltration system 1, the exosomes are located in the filtrate of the first-stage tangential flow ultrafiltration system 1. Exosomes cannot pass through the ultrafiltration membrane of the second-stage tangential flow ultrafiltration system 2.

[0064] S3: The enriched liquid in the enriched liquid container 22 is circulated and ultrafiltered again by the circulation pump 5, and finally the purified and concentrated exosome enriched liquid is obtained in the enriched liquid container 22 of the second ultrafiltration system.

[0065] The exosome-enriched liquid prepared by the device of Example 1 and the methods of Examples 2-4 of the present invention can concentrate the cell culture supernatant to 0.5%-80% of the original volume; can increase the exosome content to 1.25-200 times that before separation and purification. The present invention can pretreat untreated cell culture medium, perform impurity removal and concentration operations, and can be installed at the upstream of the separation and purification of exosomes. The present invention can automate the operations of separation, purification, enrichment and concentration to process a large amount of liquid to be extracted, and the purity of separation and purification is high, which has high commercial value.

[0066] Although the present disclosure is disclosed as above, the protection scope of the present disclosure is not limited thereto. Those skilled in the art can make various changes and modifications without departing from the spirit and scope of the present disclosure, and these changes and modifications will fall within the protection scope of the present invention.

Claims

1. A secondary two-stage tangential flow ultrafiltration method for separation, purification and concentration of exosomes, characterized in that: Ultrafiltration is performed using an ultrafiltration device, the ultrafiltration device comprising a first-stage tangential flow ultrafiltration system (1), a first peristaltic pump (4), and a second-stage tangential flow ultrafiltration system (2) which are sequentially connected via a pipeline (3), the first peristaltic pump (4) being used to drive liquid in the first-stage tangential flow ultrafiltration system (1) to flow to the second-stage tangential flow ultrafiltration system (2); The first-stage tangential flow ultrafiltration system (1) is provided with a first filter membrane (11), and the second-stage tangential flow ultrafiltration system (2) is provided with a second filter membrane (21); the first filter membrane (11) and the second filter membrane (21) are connected via the first peristaltic pump (4); the filter pore diameter of the second filter membrane (21) is smaller than the filter pore diameter of the first filter membrane (11); The ultrafiltration method comprises the following steps: S1: introducing a liquid to be extracted containing exosomes into a pipeline (3), wherein the liquid to be extracted flows through a first filter membrane of a first-stage tangential flow ultrafiltration system (1) for primary filtration to obtain a filtrate; the pore size of the filtration pores of the first filter membrane is larger than that of the exosomes; S2: the filtrate of step S1 flows through the second filter membrane of the second-stage tangential flow ultrafiltration system (2) to be filtered again for enrichment and concentration, thereby obtaining a filtrate filtered by the second filter membrane (21) and a purified exosome enriched solution; the pore size of the second filter membrane (21) is smaller than that of the exosomes; S3: The exosome-enriched liquid obtained in step S2 is subjected to a second-stage tangential flow ultrafiltration process to finally obtain a purified and concentrated exosome-enriched liquid in a second-stage tangential flow ultrafiltration system (2).

2. The method for secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 1, characterized in that: The filtration pore size of the first filter membrane (11) is greater than or equal to 0.18 μm, and the filtration pore size of the second filter membrane (21) is less than or equal to 0.03 μm; and both the first filter membrane and the second filter membrane are cassette-type flat membranes.

3. The method for secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 1, characterized in that: A filtrate container (12) is provided in the first-stage tangential flow ultrafiltration system (1), and an enriched liquid container (22) is provided in the second-stage tangential flow ultrafiltration system (2). The filtrate container (12) is connected to the downstream of the first filter membrane (11) through the pipeline (3), and the enriched liquid container (22) is connected to the upstream and downstream of the second filter membrane (21) through the pipeline (3), so that when the liquid flows in the ultrafiltration device, the liquid that passes through the first filter membrane (11) flows into the filtrate container (12), and the liquid that does not pass through the second filter membrane (21) flows into the enriched liquid container (22).

4. The method for secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 3, characterized in that: A one-way valve (6) and a circulation pump (5) are provided between the enriched liquid container (22) and the second filter membrane, and the flow direction of the one-way valve (6) is from the enriched liquid container (22) to the second filter membrane. The circulation pump (5) is used to drive the circulation flow of liquid inside the second-stage tangential flow ultrafiltration system (2).

5. The method for ultrafiltration of secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 4, characterized in that: The outlet end of the second filter membrane (21) is connected to a recovery container (8), and the recovery container (8) is used to recover the liquid that passes through the second filter membrane (21) after the circulation by the circulation pump (5) is completed.

6. The method for ultrafiltration of secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 1, characterized in that: The pipeline (3) at the inlet end of the first filter membrane (11) is connected to a container (7) for liquid to be extracted, so that when the liquid flows in the ultrafiltration device, the liquid that has not passed through the first filter membrane (11) flows into the container (7) for liquid to be extracted.

7. The method for ultrafiltration of secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 6, characterized in that: A second peristaltic pump (9) is provided in the first-stage tangential flow ultrafiltration system (1), and the inlet of the second peristaltic pump is connected to the container of liquid to be extracted (7), and the outlet of the second peristaltic pump is connected to the inlet end of the first filter membrane (11); the second peristaltic pump is used to drive the liquid in the container of liquid to be extracted (7) to flow to the first-stage tangential flow ultrafiltration system (1).

8. The method for ultrafiltration of secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 1, characterized in that: In the step S1, the liquid to be extracted containing exosomes is the supernatant of the cell culture medium.

9. The method for ultrafiltration of secondary two-stage tangential flow separation, purification and concentration of exosomes according to claim 1, characterized in that: In the step S3, the cyclic ultrafiltration is performed in the second-stage tangential flow ultrafiltration system (2), specifically: after the treatment in step S2, the enriched liquid is passed into the second-stage tangential flow ultrafiltration system (2) for re-ultrafiltration, and the number of re-ultrafiltration is greater than or equal to 1 time.